Business

Global Pertussis Vaccine Market Size Analysis and Regional Analysis Forecast to 2024-2032

Mr Accuracyreports has published a new research report titled “

Global Pertussis Vaccine Market Size By Type of Vaccine, By Age Group, By Distribution Channel, By Geographic Scope And Forecast

” in its research database. Get a Free Sample PDF of this Research Report for more Insights with Table of Content, Research Methodology, and Graphs –

https://www.mraccuracyreports.com/marketreports/5/857394/Pertussis-Vaccine-Market

https://www.mraccuracyreports.com/request/download/5/857394/Pertussis-Vaccine-Market

Pertussis Vaccine Market Size And Forecast

Pertussis Vaccine Market size was valued at USD 8612.77 Million in 2023 and is projected to reach USD 15429.81 Million by 2031, growing at a CAGR of 8.34% during the forecast period 2024-2031.

Global Pertussis Vaccine Market Drivers

The market drivers for the Pertussis Vaccine Market can be influenced by various factors. These may include:

  • Growing Incidence of Pertussis: The market is significantly influenced by the growing prevalence of pertussis, also known as whooping cough. The necessity for immunisation to stop the disease’s spread is growing as it continues to harm people all over the world.
  • Government Initiatives and Immunisation Programmes: As part of regular vaccination schedules, a number of governments and healthcare organisations are actively promoting immunisation against pertussis. Programmes aimed for babies, kids, teens, and adults are included in this, which helps the industry expand.
  • Technological Developments in Vaccines: Newer and safer pertussis vaccinations have been made possible by technological advancements in vaccine research. Growth in the market is fueled by these developments, which draw funding for R&D.
  • Education and Public Awareness Campaigns: Raising public awareness of the value of the pertussis vaccination through educational programmes and campaigns is essential to increasing demand. Vaccine uptake is boosted by greater awareness among the general public and healthcare professionals.
  • Increase in Healthcare Spending: The market for pertussis vaccine is growing as a result of the general increase in healthcare spending, especially in preventative healthcare measures. This covers funding for immunisation campaigns and the infrastructure needed to distribute vaccines.
  • Growing Interest in Paediatric Vaccination: There will likely be a continued high demand for pertussis vaccines due to the increased attention being paid to paediatric healthcare and the health of newborns and children. Pertussis vaccine is frequently included in paediatric vaccination schedules, which is fueling market expansion.
  • Globalisation and Travel: The ease with which people can travel the world has raised the possibility of spreading diseases, such as pertussis. Traveller vaccination laws, particularly in areas where pertussis is more common, aid in the growth of the industry.
  • Partnerships and Collaborations: These partnerships and collaborations assist market growth by facilitating vaccine access, distribution, and affordability between healthcare providers, government agencies, non-profit organisations, and vaccine makers.

Global Pertussis Vaccine Market Restraints

Several factors can act as restraints or challenges for the Pertussis Vaccine Market. These may include:

  • Limited Knowledge and Access: There may be limited knowledge about the pertussis vaccination in some areas, particularly in low-income or isolated communities, or there may be limited access to medical facilities that provide vaccination services. This may impede market expansion by limiting the reach of immunisation initiatives.
  • Vaccination expense: The expense of the pertussis vaccination can be a major obstacle, especially for people without insurance or in private healthcare settings. Affordability concerns could prevent some demographic segments from receiving vaccinations, which would hinder market expansion.
  • Difficulties with Vaccine Distribution and Storage: Pertussis vaccinations frequently need particular storage environments, such refrigeration, which can be logistically difficult, particularly in rural or underdeveloped locations. Keeping the cold chain intact increases the process’s complexity and expense.
  • Vaccine Hesitancy and Safety worries: Similar to any medical procedure, vaccinations may cause certain people or groups to have safety worries. Inaccurate information or a lack of faith in medical institutions can cause vaccine hesitation, which can impede market growth and reduce immunisation rates.
  • Regulatory Obstacles: varied nations and areas have varied regulatory regulations for the distribution and licencing of vaccines. For vaccine producers, adhering to strict regulations on clinical studies and manufacturing procedures can be difficult, which might hinder their ability to enter and grow new markets.
  • Competitive Environment: There may be pressure on prices and lower profit margins due to the existence of several vaccine makers and competition in the Pertussis Vaccine Market. Businesses may encounter difficulties efficiently differentiating their products and gaining market share.
  • Public Health Policies and financing: The demand for pertussis vaccinations may be impacted by modifications to public health policies, changes in government financing for immunisation programmes, and variations in healthcare budgets. Market volatility may result from unclear long-term funding or policy changes.

Global Pertussis Vaccine Market Segmentation Analysis

The Global Pertussis Vaccine Market is Segmented on the basis of Type of Vaccine, Age Group, Distribution Channel, and Geography.

Pertussis Vaccine Market, By Type of Vaccine

  • Whole-cell Pertussis Vaccines: These vaccines contain whole, killed Bordetella pertussis bacteria. They were the first type of pertussis vaccines developed and used widely in the past. However, they are associated with more side effects compared to acellular vaccines.
  • Acellular Pertussis Vaccines: These vaccines contain purified components of the Bordetella pertussis bacteria, such as pertussis toxin, filamentous hemagglutinin, pertactin, and fimbriae. They are newer and generally have fewer side effects, making them preferred for routine immunization.

Pertussis Vaccine Market, By Age Group

  • Infants: Pertussis vaccination in infants is crucial as they are more susceptible to severe complications of pertussis, such as pneumonia and seizures.
  • Children: Continued vaccination during childhood ensures sustained protection against pertussis.
  • Adults: Vaccination in adults, especially pregnant women and healthcare workers, helps prevent the transmission of pertussis to vulnerable populations.

Pertussis Vaccine Market, By Distribution Channel

  • Hospitals and Clinics: These are primary channels for vaccination, especially for infants and children during routine healthcare visits.
  • Retail Pharmacies: Increasingly important for adult vaccinations and convenience for individuals seeking booster doses.
  • Online Pharmacies: Emerging as a convenient option for vaccine distribution, especially during the COVID-19 pandemic when remote access to healthcare services has become more prevalent.

Pertussis Vaccine Market, By Geography

  • North America: Market conditions and demand in the United States, Canada, and Mexico.
  • Europe: Analysis of the Pertussis Vaccine Market in European countries.
  • Asia-Pacific: Focusing on countries like China, India, Japan, South Korea, and others.
  • Middle East and Africa: Examining market dynamics in the Middle East and African regions.
  • Latin America: Covering market trends and developments in countries across Latin America.

Key Players

The major players in the Pertussis Vaccine Market are:

  • Kubota
  • Deluxe Agro Industries
  • AGCO
  • Bharat Industries
  • Iseki & Co
  • ALMACO
  • Alvan Blanch
  • Wuhan Acme Agro Tech.
  • GlaxoSmithKline
  • Sanofi Pasteur
  • Pfizer Inc.
  • Serum Institute of India Pvt Ltd

Report Scope

REPORT ATTRIBUTES DETAILS
STUDY PERIOD

2020-2031

BASE YEAR

2023

FORECAST PERIOD

2024-2031

HISTORICAL PERIOD

2020-2022

UNIT

Value (USD Million)

KEY COMPANIES PROFILED

GlaxoSmithKline, Protein Sciences Corporation, Sanofi Pasteur, Novartis AG, Seqirus, Merck Sharp & Dohme Corp., and Astellas Pharma US, Inc.

SEGMENTS COVERED

By Type of Vaccine, By Age Group, By Distribution Channel, and By Geography.

CUSTOMIZATION SCOPE

Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope

Research Methodology of Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.

Frequently Asked Questions

Pertussis Vaccine Market was valued at USD 8612.77 Million in 2023 and is projected to reach USD 15429.81 Million by 2031, growing at a CAGR of 8.34% during the forecast period 2024-2031.
Growing Incidence of Pertussis, Government Initiatives and Immunisation Programmes, Technological Developments in Vaccines, and Education and Public Awareness Campaigns are the factors driving the growth of the Pertussis Vaccine Market.
The major players are GlaxoSmithKline, Protein Sciences Corporation, Sanofi Pasteur, Novartis AG, Seqirus, Merck Sharp & Dohme Corp., and Astellas Pharma US, Inc.
The Global Pertussis Vaccine Market is Segmented on the basis of Type of Vaccine, Age Group, Distribution Channel, and Geography.
The sample report for the Pertussis Vaccine Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.